Japan · Delayed Price · Currency is JPY Medikit Statistics
Total Valuation
Medikit has a market cap or net worth of JPY 42.22 billion. The enterprise value is 21.11 billion.
| Market Cap | 42.22B |
| Enterprise Value | 21.11B |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Medikit has 14.62 million shares outstanding. The number of shares has decreased by -4.53% in one year.
| Current Share Class | 14.62M |
| Shares Outstanding | 14.62M |
| Shares Change (YoY) | -4.53% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 7.84% |
| Owned by Institutions (%) | 18.61% |
| Float | 4.73M |
Valuation Ratios
The trailing PE ratio is 13.71.
| PE Ratio | 13.71 |
| Forward PE | n/a |
| PS Ratio | 1.82 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | 112.30 |
| P/OCF Ratio | 9.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.31, with an EV/FCF ratio of 56.15.
| EV / Earnings | 6.84 |
| EV / Sales | 0.91 |
| EV / EBITDA | 3.31 |
| EV / EBIT | 4.68 |
| EV / FCF | 56.15 |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.92 |
| Quick Ratio | 4.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.02 |
| Interest Coverage | 644.00 |
Financial Efficiency
Return on equity (ROE) is 6.83% and return on invested capital (ROIC) is 6.23%.
| Return on Equity (ROE) | 6.83% |
| Return on Assets (ROA) | 5.39% |
| Return on Invested Capital (ROIC) | 6.23% |
| Return on Capital Employed (ROCE) | 9.61% |
| Revenue Per Employee | 23.45M |
| Profits Per Employee | 3.12M |
| Employee Count | 989 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.12 |
Taxes
In the past 12 months, Medikit has paid 1.65 billion in taxes.
| Income Tax | 1.65B |
| Effective Tax Rate | 34.89% |
Stock Price Statistics
The stock price has increased by +5.82% in the last 52 weeks. The beta is 0.15, so Medikit's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +5.82% |
| 50-Day Moving Average | 2,723.90 |
| 200-Day Moving Average | 2,600.08 |
| Relative Strength Index (RSI) | 75.58 |
| Average Volume (20 Days) | 5,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medikit had revenue of JPY 23.19 billion and earned 3.09 billion in profits. Earnings per share was 210.70.
| Revenue | 23.19B |
| Gross Profit | 8.95B |
| Operating Income | 4.51B |
| Pretax Income | 4.74B |
| Net Income | 3.09B |
| EBITDA | 6.39B |
| EBIT | 4.51B |
| Earnings Per Share (EPS) | 210.70 |
Balance Sheet
The company has 21.12 billion in cash and 8.00 million in debt, giving a net cash position of 21.11 billion or 1,444.48 per share.
| Cash & Cash Equivalents | 21.12B |
| Total Debt | 8.00M |
| Net Cash | 21.11B |
| Net Cash Per Share | 1,444.48 |
| Equity (Book Value) | 45.74B |
| Book Value Per Share | 3,127.65 |
| Working Capital | 27.48B |
Cash Flow
In the last 12 months, operating cash flow was 4.63 billion and capital expenditures -4.25 billion, giving a free cash flow of 376.00 million.
| Operating Cash Flow | 4.63B |
| Capital Expenditures | -4.25B |
| Free Cash Flow | 376.00M |
| FCF Per Share | 25.73 |
Margins
Gross margin is 38.60%, with operating and profit margins of 19.44% and 13.30%.
| Gross Margin | 38.60% |
| Operating Margin | 19.44% |
| Pretax Margin | 20.43% |
| Profit Margin | 13.30% |
| EBITDA Margin | 27.54% |
| EBIT Margin | 19.44% |
| FCF Margin | 1.62% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 3.60%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 3.60% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 42.88% |
| Buyback Yield | 4.53% |
| Shareholder Yield | 8.13% |
| Earnings Yield | 7.31% |
| FCF Yield | 0.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Medikit has an Altman Z-Score of 5.8 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.8 |
| Piotroski F-Score | 6 |